瘤微环境和免疫治疗中的树突细胞功能障碍
Jie Chen1, Yuhang Duan2,3, Junye Che1
1Jecho Institute Co., Ltd, Shanghai, P. R. China.
Cancer communications (London, England)
|July 25, 2024
概括
树突细胞 (DCs) 对于免疫反应至关重要,但在癌症中可能受到损害. 本综述详细介绍了导致DC功能障碍的因素,并讨论了针对DC的免疫疗法,以增强抗瘤免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症免疫疗法癌症免疫疗法
背景情况:
- 树突细胞 (DCs) 对于抗原呈现和启动免疫反应至关重要.
- 瘤微环境 (TME) 中的DC功能障碍可能导致癌症免疫逃避.
- 了解DC异质性和功能障碍是有效的癌症免疫治疗的关键.
研究的目的:
- 审查TME中诱导DC功能障碍的因素.
- 为了识别参与DC功能障碍的信号通路和药物.
- 总结针对DC的当前临床免疫疗法,并探索未来的方向.
主要方法:
- 对影响TME直流功能的因素的文献综述.
- 对涉及DC功能障碍的信号通路的分析.
- 对DC向免疫疗法的临床试验和结果的摘要.
主要成果:
- 鉴定了细胞因子,缺氧,瘤外体,代谢物和联合抑制分子作为诱导DC功能障碍的因素.
- 突出了临床试验中的关键信号通路和相关药物.
- 提供了当前DC向免疫疗法与临床结果的概述.
结论:
- 在TME中调节DC功能对于克服癌症免疫逃避至关重要.
- 针对DC提供了增强癌症免疫疗法疗效的有希望的策略.
- 未来的研究应该专注于基于DC的新型免疫疗法,这些免疫疗法具有已证明的临床益处.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
11.4K
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
Cytotoxic T Cells-mediated Immune Response
883
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
883
Cell-mediated Immune Responses
68.0K
Overview
68.0K
T Cell Activation and Clonal Selection
694
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
694
Cancer Vaccines
348
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
348
